LY-367,265

chemical compound

Uses your system voice; voice and rate in settings.

Q15409397Snapshot

≈ 1 min read

Names in other languages

  • EnglishLY-367,265
  • shLY-367,265
  • СрпскиLY-367,265

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LY-367,265 is a drug of the tetrahydropyridinylindole group developed by Eli Lilly, which acts as both a potent and selective antagonist at the serotonin 5-HT 2A receptor, and also a selective serotonin reuptake inhibitor (SSRI). It has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine.

See also

Tetrahydropyridinylindole Substituted tryptamine § Related compounds

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338610694 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.